Daniel D. Burton, Chief Executive Officer at Health Catalyst, Inc. (HCAT), sold 343,224 shares at $31.41 ($10.9M) on 2020-08-14, disclosed to the SEC on 2020-08-18.
Open-market sale of $10.9M HCAT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.41 | 61,190 | $1.9M | 17.6% |
| 2 | $31.41 | 61,190 | $1.9M | 17.6% |
| 3 | $32.05 | 37,485 | $1.2M | 11.0% |
| 4 | $32.05 | 37,485 | $1.2M | 11.0% |
| 5 | $32.05 | 72,937 | $2.3M | 21.4% |
| 6 | $32.05 | 72,937 |
| $2.3M |
| 21.4% |
| Total | $31.82 avg | 343,224 | $10.9M | 100% |
| Filing → |
| HCAT | BUY | 2022-11-14 | $4.0M | — | Filing → |
| HCAT | BUY | 2022-09-08 | $2.0M | — | Filing → |
| HCAT | BUY | 2022-08-09 | $4.1M | — | Filing → |